Stimulant medications, and atomoxetine (a type of antidepressant), were more effective than placebos at reducing core ADHD symptoms during a 12-week period, found the study published Tuesday in the journal Lancet Psychiatry.
Prior to conducting this study, Cortese and several other study authors had various types of affiliations — such as for consulting or research — with pharmaceutical companies, some of which manufacture ADHD medications.
They also mention non-pharmacological treatment if medication is not effective or not well tolerated, but they don’t specify which kind of non-pharmacological treatment.
“Self-perception of ADHD symptoms is fallible in all people.
However, there are no ‘objective’ tests that can accurately measure ADHD symptoms.
Persons:
—, Samuele Cortese, Cortese, “, It’s, ” Cortese, atomoxetine, ”, Philip Shaw, Shaw, wasn’t, Margaret Sibley, University of Washington School of Medicine . Sibley wasn’t, Edoardo G, Ostinelli, ” Sibley, Dr, Alessio Bellato, Sibley
Organizations:
CNN, University of Southampton, Science Media Centre, Harvard University’s Center, of Psychiatry, Neuroscience, King’s College London, Science Media, University of Washington School of Medicine ., University of Oxford’s Oxford Precision Psychiatry
Locations:
England